Ghent University Academic Bibliography

Journal Article
A1
open access

Pharmacogenetics of inhaled corticosteroids and exacerbation risk in adults with asthma

Ahmed Edris Mohamed, Emmely de Roos, Michael J. McGeachie, Katia Verhamme (UGent) , Guy Brusselle (UGent) , Kelan G. Tantisira, Carlos Iribarren, Meng Lu, Ann Chen Wu, Bruno H. Stricker, et al.

(2022) CLINICAL AND EXPERIMENTAL ALLERGY. 52(1). p.33-45

Add to list

Responder analysis to demonstrate the effect of targeting type 2 inflammatory mechanisms with dupilumab across objective and patient‐reported endpoints for patients with severe chronic rhinosinusitis with nasal polyps in the SINUS‐24 and SINUS‐52 studies

Claus Bachert (UGent) , Anju T. Peters, Enrico Heffler, Joseph K. Han, Heidi Olze, Oliver Pfaar, Chien‐Chia Chuang, Raj Rout, Richa Attre, Ledia Goga, et al.

(2022) CLINICAL AND EXPERIMENTAL ALLERGY. 52(2). p.244-249

Add to list

A responder analysis to demonstrate dupilumab treatment effect across objective and patient-reported endpoints for patients with severe chronic rhinosinusitis with nasal polyps (CRSwNP)

Claus Bachert (UGent) , Anju T. Peters, Enrico Heffler, Joseph K. Han, Heidi Olze, Oliver Pfaar, Shahid Siddiqui and Raj Rout

(2021) CLINICAL AND EXPERIMENTAL ALLERGY. In Clinical and Experimental Allergy 51(12). p.1665-1666

Add to list

Efficacy of dupilumab in chronic rhinosinusitis with nasal polyps and comorbid asthma by baseline biomarkers of type 2 inflammation: SINUS-24 and SINUS-52 phase 3 trials

J. F. Maspero, Claus Bachert (UGent) , G. W. Canonica, B. N. Swanson, S. H. Cho, S. Harel, A. Jagerschmidt, M. Zhang, X. Mao, L. P. Mannent, et al.

(2021) CLINICAL AND EXPERIMENTAL ALLERGY. 51(1). p.173-174

Add to list

Journal Article
A1
open access

Heterogeneity of the pharmacologic treatment of allergic rhinitis in Europe based on MIDAS and OTCims platforms

Jean Bousquet, Detlef Schröder‐Bernhardi, Claus Bachert (UGent) , G. Walter Canonica, Victoria Cardona, Elisio M. Costa, Wienczyslawa Czarlewski, Philippe Devillier, Joao A. Fonseca, Ludger Klimek, et al.

(2021) CLINICAL AND EXPERIMENTAL ALLERGY. 51(8). p.1033-1045

Add to list

ADRB2 haplotypes and asthma exacerbations in children and young adults : an individual participant data meta-analysis

Leila Karimi, Susanne J. Vijverberg, Marjolein Engelkes, Natalia Hernandez-Pacheco, Niloufar Farzan, Patricia Soares, Maria Pino-Yanes, Andrea L. Jorgensen, Celeste Eng, Somnath Mukhopadhyay, et al.

(2021) CLINICAL AND EXPERIMENTAL ALLERGY. 51(9). p.1157-1171

Add to list

Impaired small airway function in non-asthmatic chronic rhinosinusitis with nasal polyps

Kun Du, Ming Zheng, Yan Zhao, Wenbin Xu, Yun Hao, Yue Wang, Jinming Zhao, Nan Zhang (UGent) , Xiangdong Wang, Luo Zhang, et al.

(2020) CLINICAL AND EXPERIMENTAL ALLERGY. 50(12). p.1362-1371

Add to list

Journal Article
A1
open access

An anti-siglec-8 antibody depletes sputum eosinophils from asthmatic subjects and inhibits lung mast cells

Sheena C. Kerr, Jeanmarie R. Gonzalez, Julia Schanin, Michael C. Peters, Bart Lambrecht (UGent) , Emily C. Brock, Annabelle Charbit, K. Mark Ansel, Bradford A. Youngblood and John V. Fahy

(2020) CLINICAL AND EXPERIMENTAL ALLERGY. 50(8). p.904-914

Add to list

Journal Article
A1
open access

Antihistamine‐resistant chronic spontaneous urticaria remains undertreated : 2‐year data from the AWARE study

Marcus Maurer, Celia Costa, AnaMaria Gimenez Arnau, Gerard Guillet, Moises Labrador‐Horrillo, Hilde Lapeere (UGent) , Raisa Meshkova, Sinisa Savic and Nadine Chapman‐Rothe

(2020) CLINICAL AND EXPERIMENTAL ALLERGY. 50(10). p.1166-1175

Add to list

Epigenome-wide association studies in asthma : a systematic review

Ahmed Edris Mohamed, Herman T den Dekker, Erik Melén and Lies Lahousse (UGent)

(2019) CLINICAL AND EXPERIMENTAL ALLERGY. 49(7). p.953-968

Academic Bibliography

Pharmacogenetics of inhaled corticosteroids and exacerbation risk in adults with asthma

Responder analysis to demonstrate the effect of targeting type 2 inflammatory mechanisms with dupilumab across objective and patient‐reported endpoints for patients with severe chronic rhinosinusitis with nasal polyps in the SINUS‐24 and SINUS‐52 studies

A responder analysis to demonstrate dupilumab treatment effect across objective and patient-reported endpoints for patients with severe chronic rhinosinusitis with nasal polyps (CRSwNP)

Efficacy of dupilumab in chronic rhinosinusitis with nasal polyps and comorbid asthma by baseline biomarkers of type 2 inflammation: SINUS-24 and SINUS-52 phase 3 trials

Heterogeneity of the pharmacologic treatment of allergic rhinitis in Europe based on MIDAS and OTCims platforms

ADRB2 haplotypes and asthma exacerbations in children and young adults : an individual participant data meta-analysis

Impaired small airway function in non-asthmatic chronic rhinosinusitis with nasal polyps

An anti-siglec-8 antibody depletes sputum eosinophils from asthmatic subjects and inhibits lung mast cells

Antihistamine‐resistant chronic spontaneous urticaria remains undertreated : 2‐year data from the AWARE study

Epigenome-wide association studies in asthma : a systematic review

Contents

Support

Contact